An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Enovis Corporation (NYSE: ENOV) will host an investor conference call and webcast to discuss its fourth quarter and full year 2023 financial results on February 22, 2024. The company will also issue an earnings press release earlier that morning and make a presentation available on its website. Investors can access the live webcast via a link on the Enovis website and a replay will be available later that day.
Positive
None.
Negative
None.
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2023 financial results on Thursday, February 22, 2024 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
colfax fluid handling is a world leader in the development, engineering, manufacturing, distribution, service and support of pumping and fluid-handling systems. specializing in positive displacement and centrifugal technologies, our products support a wide range of industries, from power generation and oil & gas to commercial and navy marine to a broad range of industrial applications. for over 10 years, colfax fluid handling has remained at the forefront of fluid-handling management by focusing on customer needs for precision performance around the world with a portfolio of pump products, deep expertise in critical applications, strong global resources and a company-wide commitment to excellence through processes such as the colfax business system. colfax brings together brands that have led their markets throughout the americas, europe, the middle east, africa and asia/pacific for decades. through its allweiler, houttuin, imo, portland valve, tushaco, warren, and zenith products, c